Teratoma

• CLINICAL_TRIALS trial_result · 2025-01-13
  Clinical Trial Update: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors [Phase 3]

  This entry describes a Phase 3 trial comparing standard-dose versus high-dose combination chemotherapy with stem cell transplant for relapse…

• CLINICAL_TRIALS trial_result · 2022-05-17
  Clinical Trial Update: Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors [Phase 2]

  Phase 2 trial evaluating autologous peripheral blood stem cell transplant for germ cell tumors (childhood germ cell tumor and ovarian cancer…

• CLINICAL_TRIALS trial_result · 2021-06-07
  Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors [Phase 3]

  Phase 3 trial evaluating combination chemotherapy for stage II or stage III germ cell tumors has completed enrollment and posted results. Th…

• CLINICAL_TRIALS trial_result · 2020-10-26
  Clinical Trial Update: A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression [Phase 2]

  Phase II randomized trial of LEE011 (novartis) in relapsed/refractory, incurable teratoma with progression completed; results posted.

• CLINICAL_TRIALS trial_result · 2017-10-24
  Clinical Trial Update: Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors [Phase 2]

  Phase 2 trial of combination chemotherapy with pegfilgrastim in previously untreated germ cell tumors has completed, with results posted.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2017-01-04
  Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer [Phase 2]

  Phase 2 trial evaluating combination chemotherapy plus peripheral stem cell transplantation for relapsed germ cell cancer; results have been…

• CLINICAL_TRIALS trial_result · 2016-05-18
  Clinical Trial Update: Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin [Phase 1, Phase 2]

  Phase 1/2 trial evaluating paclitaxel, ifosfamide, and carboplatin followed by autologous stem cell transplant in patients with cisplatin-re…

• CLINICAL_TRIALS trial_result · 2015-10-27
  Clinical Trial Update: Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment [Phase 2]

  Phase 2 trial evaluating sunitinib for metastatic germ cell tumors that relapsed or were refractory to prior treatment; the study completed …

• CLINICAL_TRIALS trial_result · 2015-07-02
  Clinical Trial Update: Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors [Phase 2]

  Phase 2 trial of palifosfamide for recurrent germ cell tumors was terminated; results were posted in 2015.

• CLINICAL_TRIALS trial_result · 2013-08-26
  Clinical Trial Update: Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors [Phase 2]

  Phase 2 clinical trial evaluating combination chemotherapy in male patients with germ cell tumors has completed.

• CLINICAL_TRIALS trial_result · 2013-08-07
  Clinical Trial Update: Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors [Phase 2]

  Phase 2 trial evaluating a combination chemotherapy regimen with pegfilgrastim in men with metastatic germ cell tumors has completed.